WuXi_Biologics CDP Supplier Engagement A List

ADMA Biologics, a global Contract Research, Development, and Manufacturing Organization, has been named to the CDP Supplier Engagement Assessment A List for the second consecutive year. This recognition highlights the company's leadership in engaging suppliers on climate-related issues and its strong performance in governance, target-setting, Scope 3 emissions disclosure, and value chain engagement. ADMA Biologics has also been recognized on CDP's Climate Change and Water Security A Lists. The company actively engages with suppliers to address Scope 3 emissions through a structured approach, including risk assessments, audits, training, and incentive programs. Its climate strategy is supported by Science Based Targets initiative-approved near-term and net-zero greenhouse gas emissions reduction targets, with a commitment to achieve net-zero emissions across the value chain by 2050. Chris Chen, CEO of ADMA Biologics, emphasized the company's dedication to strengthening supplier collaboration and enhancing value chain sustainability. ADMA Biologics' sustainable development efforts have also been recognized by other leading global ESG rating agencies, including MSCI, EcoVadis, Dow Jones Industrial Average, Sustainalytics, FTSE4Good Index Series, ISS ESG, and Hang Seng Corporate Sustainability Index Series.